Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.1B | 3.1B | 2.8B |
Cost of revenue | 1.2B | 1.2B | 1.2B | 1.1B |
Gross profit | 2.0B | 1.9B | 1.9B | 1.7B |
Operating expense | ||||
Research & development | 353.0M | 338.0M | 346.2M | 323.1M |
Selling general and admin | 262.7M | 248.9M | 267.1M | 251.0M |
Other operating expenses | — | — | — | — |
Operating income | 1.4B | 1.3B | 1.2B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 73.1M | 71.9M | 75.0M | 82.2M |
Other income expense | -130.1M | 35.9M | -194.6M | 40.9M |
Pretax income | 1.3B | 1.3B | 972.5M | 1.1B |
Tax provision | 126.0M | 176.0M | 148.0M | 132.8M |
Net income | 1.2B | 1.1B | 824.5M | 945.9M |
Basic EPS | — | 8.2 | 6.2 | 7.1 |
Diluted EPS | — | 8.2 | 6.2 | 7.0 |
Basic average shares | — | 132.6M | 133.3M | 134.1M |
Diluted average shares | — | 133.3M | 133.9M | 134.9M |
EBITDA | 1.5B | 1.4B | 1.4B | 1.3B |
Net income from continuing op. | 1.2B | 1.1B | 824.5M | 945.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |